Virios Therapeutics
(NASDAQ:VIRI)
$0.4384
0.0127[2.98%]
Last update: 8:59AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Virios Therapeutics Stock (NASDAQ:VIRI), Quotes and News Summary

Virios Therapeutics Stock (NASDAQ: VIRI) stock price, news, charts, stock research, profile.

Open$0.430
Close-
Volume / Avg.28.006K / 372.589K
Day Range0.421 - 0.446
52 Wk Range0.279 - 2.420
Market Cap$8.443M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
49
Short Interest
1.2%
Days to Cover1

Recent News

Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.27% to 37,967.81 while the NASDAQ rose 0.31% to 15,358.70. The S&P 500 also rose, gaining, 0.23% to 4,850.71.
Avi Kapoor
Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the price target from $2.1 to $2. CommScope shares dipped 6.9% to $2.2150 on Monday.
Avi Kapoor
Crude Oil Surges Over 2%; US Leading Economic Index Falls In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded up 0.41% to 38,018.23 while the NASDAQ rose 0.30% to 15,356.67. The S&P 500 also rose, gaining, 0.25% to 4,851.78.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Virios Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VIRI
CANF

FAQ

Q

How do I buy Virios Therapeutics (VIRI) stock?

A

You can purchase shares of Virios Therapeutics (NASDAQ: VIRI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Virios Therapeutics's (VIRI) competitors?

A

Other companies in Virios Therapeutics’s space includes: Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), NuCana (NASDAQ:NCNA), Longeveron (NASDAQ:LGVN) and Trevena (NASDAQ:TRVN).

Q

What is the target price for Virios Therapeutics (VIRI) stock?

A

The latest price target for Virios Therapeutics (NASDAQ: VIRI) was reported by HC Wainwright & Co. on Tuesday, September 20, 2022. The analyst firm set a price target for 0.00 expecting VIRI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Virios Therapeutics (VIRI)?

A

The stock price for Virios Therapeutics (NASDAQ: VIRI) is $0.4384 last updated Today at April 23, 2024 at 8:59 AM EDT.

Q

Does Virios Therapeutics (VIRI) pay a dividend?

A

There are no upcoming dividends for Virios Therapeutics.

Q

When is Virios Therapeutics (NASDAQ:VIRI) reporting earnings?

A

Virios Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Virios Therapeutics (VIRI) going to split?

A

There is no upcoming split for Virios Therapeutics.

Q

What sector and industry does Virios Therapeutics (VIRI) operate in?

A

Virios Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch